India Drug Industry Urged To Look Away From U.S. To CIS Nations
This article was originally published in PharmAsia News
Executive Summary
India's pharmaceutical industry is expected to suffer more than any other sector under the new U.S. presidency of Barack Obama, according to Promed Group President Deepak Bahri. The group makes and markets branded and generic drugs globally. Bahri said the new administration is likely to clamp down on outsourcing to the Indian market and allow greater generics competition to Indian drugs in the United States. He also advised drug makers to focus more on the former Soviet countries that have formed the Commonwealth of Independent States, a group making major changes in old health care systems. (Click here for more